Study to Evaluate the Safety and Efficacy of AM3101 to Augment Meniscal Healing — StellaPhase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(3 sites)
United States
University of Cincinnati, Cincinnati, Ohio University Hospitals Cleveland Medical Center, Cleveland, Ohio Oregon Health & Science University, Portland, Oregon Age range
18 Years – 40 Years
Last updated December 2025